精神医学57巻9号

2015年09月発行

特集 統合失調症の認知機能障害の臨床的意義

認知機能障害の臨床的問題点について

著者： 兼田康宏¹

所属機関： ¹岩城クリニック心療内科

ページ範囲：P.697 - P.702

はじめに
　本稿では，認知機能障害，主に統合失調症における認知機能障害とその臨床的な問題点について述べる。

参考文献

1) Blatter K, Cajochen C：Circadian rhythms in cognitive performance：Methodological constraints, protocols, theoretical underpinnings. Physiol Behav 90：196-208, 2007

2) Buchanan RW, Davis M, Goff D, et al：A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31：5-19, 2005

3) Buchanan RW, Keefe RS, Umbricht D, et al：The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs：What do we know 5 years later? Schizophr Bull 37：1209-1217, 2011

4) Ertugrul A, Ulug B：The influence of neurocognitive deficits and symptoms on disability in schizophrenia. Acta Psychiatr Scand 105：196-201, 2002

5) Goldberg TE, Keefe RS, Goldman RS, et al：Circumstances under which practice does not make perfect：A review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology 35：1053-1062, 2010

6) Green MF：What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153：321-330, 1996

7) Green MF, Kern RS, Braff DL, et al：Neurocognitive deficits and functional outcome in schizophrenia：Are we measuring the “right stuff” ? Schizophr Bull 26：119-136, 2000

8) Hufford MR, Davis VG, Hilt D, et al：Circadian rhythms in cognitive functioning among patients with schizophrenia：Impact on signal detection in clinical trials of potential pro-cognitive therapies. Schizophr Res 159：205-210, 2014

9) Kaneda Y：Verbal working memory and functional outcome in patients with unipolar major depressive disorder. World J Biol Psychiatry 10：591-594, 2009

10) Kaneda Y：Working Memory and Functional Outcome in Patients with Major Depressive Disorder. In：Levin ES, ed. Working Memory：Capacity, Developments and Improvement Techniques. Nova Science Publishers, New York, pp369-376, 2011

11) Kaneda Y, Jayathilak K, Meltzer H：Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder：Cognitive impairment and clozapine treatment. Psychiatry Res 178：57-62, 2010

12) Kaneda Y, Jayathilak K, Meltzer HY：Determinants of work outcome in schizophrenia and schizoaffective disorder：Role of cognitive function. Psychiatry Res 169：178-179, 2009

13) Kaneda Y, Ohmori T, Okahisa Y, et al：Measurement and treatment research to improve cognition in schizophrenia consensus cognitive battery：Validation of the Japanese version. Psychiatry Clin Neurosci 67：182-188, 2013

14) Kaneda Y, Sumiyoshi T, Keefe R, et al：Brief assessment of cognition in schizophrenia：Validation of the Japanese version. Psychiatry Clin Neurosci 61：602-609, 2007

15) 兼田康宏，住吉太幹，中込和幸，他：統合失調症認知機能簡易評価尺度日本語版(BACS-J)．精神医学 50：913-917, 2008

16) Keefe RS, Buchanan RW, Marder SR, et al：Clinical trials of potential cognitive-enhancing drugs in schizophrenia：What have we learned so far? Schizophr Bull 39：417-435, 2013

17) Keefe RS, Fox KH, Harvey PD, et al：Characteristics of the MATRICS consensus cognitive battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res 125：161-168, 2011

18) Keefe RS, Goldberg TE, Harvey PD, et al：The brief assessment of cognition in schizophrenia：Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68：283-297, 2004

19) Keefe RS, Harvey PD：Implementation considerations for multisite clinical trials with cognitive neuroscience tasks. Schizophr Bull 34：656-663, 2008

20) Loong J：The manual for the continuous performance test. Wang Neuropsychological Laboratory, San Luis Obispo, 1991

21) Lystad JU, Falkum E, Mohn C, et al：The MATRICS Consensus Cognitive Battery(MCCB)：Performance and functional correlates. Psychiatry Res 220：1094-1101, 2014

22) McGurk SR, Green MF, Wirshing WC, et al：Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68：225-233, 2004

23) McIntyre R, Kennedy S, Bagby RM, et al：Assessing full remission. J Psychiatry Neurosci 27：235-239, 2002

24) Mohamed S, Paulsen JS, O'Leary D, et al：Generalized cognitive deficits in schizophrenia：A study of first-episode patients. Arch Gen Psychiatry 56：749-754, 1999

25) Norman RM, Malla AK, Cortese L, et al：Symptoms and cognition as predictors of community functioning：A prospective analysis. Am J Psychiatry 156：400-405, 1999

26) Nuechterlein KH, Green MF, Kern RS, et al：The MATRICS Consensus Cognitive Battery, part 1：Test selection, reliability, and validity. Am J Psychiatry 165：203-213, 2008

27) Peterson L, Peterson MJ：Short-term retention of individual verbal items. J Exp Psychol 58：193-198, 1959

28) Schmidt C, Collette F, Cajochen C, et al：A time to think：Circadian rhythms in human cognition. Cogn Neuropsychol 24：755-789, 2007